Mikhail Ivanovich Papisov, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iodine Radioisotopes | 4 | 2012 | 1030 | 0.660 |
Why?
|
| Acids, Heterocyclic | 1 | 2012 | 1 | 0.450 |
Why?
|
| Sulfuric Acid Esters | 1 | 2012 | 33 | 0.440 |
Why?
|
| Drug Delivery Systems | 4 | 2013 | 2217 | 0.400 |
Why?
|
| Polymers | 3 | 2005 | 1618 | 0.330 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 518 | 0.320 |
Why?
|
| Biocompatible Materials | 3 | 2005 | 1731 | 0.310 |
Why?
|
| Radiopharmaceuticals | 3 | 2019 | 2658 | 0.300 |
Why?
|
| Pentetic Acid | 4 | 2005 | 213 | 0.300 |
Why?
|
| Lymph Nodes | 5 | 2005 | 3465 | 0.260 |
Why?
|
| Contrast Media | 8 | 2019 | 5295 | 0.250 |
Why?
|
| Phagocytes | 1 | 2005 | 297 | 0.220 |
Why?
|
| Drug Carriers | 4 | 1996 | 692 | 0.220 |
Why?
|
| Positron-Emission Tomography | 5 | 2019 | 6259 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2015 | 8300 | 0.210 |
Why?
|
| Camptothecin | 1 | 2004 | 572 | 0.190 |
Why?
|
| Glycine | 1 | 2004 | 671 | 0.190 |
Why?
|
| Rats | 16 | 2019 | 24265 | 0.180 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2019 | 48 | 0.170 |
Why?
|
| Macromolecular Substances | 3 | 2013 | 1456 | 0.170 |
Why?
|
| Tissue Distribution | 7 | 2019 | 2335 | 0.170 |
Why?
|
| Nanotechnology | 1 | 2005 | 709 | 0.170 |
Why?
|
| Isotope Labeling | 2 | 2019 | 414 | 0.150 |
Why?
|
| Magnetics | 6 | 1988 | 609 | 0.150 |
Why?
|
| Dimethylformamide | 2 | 2015 | 21 | 0.150 |
Why?
|
| Drug Design | 2 | 2019 | 1078 | 0.140 |
Why?
|
| Axonal Transport | 2 | 2013 | 177 | 0.140 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2015 | 10 | 0.130 |
Why?
|
| Isradipine | 1 | 2015 | 14 | 0.130 |
Why?
|
| Injections, Spinal | 2 | 2013 | 303 | 0.130 |
Why?
|
| Cations | 2 | 2005 | 231 | 0.130 |
Why?
|
| Organometallic Compounds | 2 | 1996 | 665 | 0.130 |
Why?
|
| Kinetics | 5 | 2005 | 6474 | 0.130 |
Why?
|
| Rejuvenation | 1 | 2015 | 91 | 0.120 |
Why?
|
| Hydrolysis | 2 | 2005 | 682 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 324 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 895 | 0.110 |
Why?
|
| Myosins | 1 | 1995 | 409 | 0.110 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 135 | 0.110 |
Why?
|
| Carbohydrates | 2 | 2005 | 391 | 0.110 |
Why?
|
| Models, Chemical | 2 | 2005 | 626 | 0.110 |
Why?
|
| Triazoles | 1 | 2019 | 907 | 0.110 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 349 | 0.110 |
Why?
|
| Glucose | 1 | 2005 | 4391 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 72 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2542 | 0.110 |
Why?
|
| Iduronate Sulfatase | 1 | 2012 | 11 | 0.110 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 694 | 0.100 |
Why?
|
| Epidermis | 1 | 2015 | 527 | 0.100 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2012 | 27 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 689 | 0.100 |
Why?
|
| Ferric Compounds | 3 | 1993 | 374 | 0.100 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2012 | 78 | 0.100 |
Why?
|
| Solvents | 1 | 2012 | 302 | 0.100 |
Why?
|
| Meninges | 1 | 2013 | 190 | 0.100 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 1015 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 2552 | 0.090 |
Why?
|
| Rabbits | 6 | 2005 | 4886 | 0.090 |
Why?
|
| Animals | 25 | 2019 | 168561 | 0.090 |
Why?
|
| Haplorhini | 1 | 2011 | 551 | 0.090 |
Why?
|
| Proteins | 1 | 2005 | 6096 | 0.090 |
Why?
|
| Rats, Inbred F344 | 2 | 2005 | 862 | 0.090 |
Why?
|
| Dextrans | 4 | 2005 | 592 | 0.090 |
Why?
|
| Oxides | 3 | 1994 | 405 | 0.090 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 605 | 0.090 |
Why?
|
| Polysaccharides | 2 | 2005 | 1051 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3800 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 8 | 1996 | 35342 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2005 | 3760 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1740 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2187 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2007 | 378 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6347 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1995 | 2036 | 0.070 |
Why?
|
| Models, Animal | 1 | 2013 | 2170 | 0.070 |
Why?
|
| Ketoses | 1 | 2005 | 3 | 0.070 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 448 | 0.070 |
Why?
|
| Drug Stability | 2 | 2004 | 290 | 0.070 |
Why?
|
| Ethylenediamines | 1 | 2005 | 48 | 0.070 |
Why?
|
| Gels | 2 | 2005 | 427 | 0.070 |
Why?
|
| Polyethylene Glycols | 2 | 2005 | 1181 | 0.060 |
Why?
|
| Polylysine | 1 | 2005 | 133 | 0.060 |
Why?
|
| Tissue Engineering | 2 | 2005 | 1877 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2005 | 5454 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 153 | 0.060 |
Why?
|
| Biopolymers | 1 | 2005 | 189 | 0.060 |
Why?
|
| Half-Life | 2 | 2015 | 658 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2005 | 13655 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2012 | 1354 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 760 | 0.060 |
Why?
|
| Oxygen | 2 | 2005 | 4169 | 0.060 |
Why?
|
| Particle Size | 2 | 2005 | 1640 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 1996 | 1420 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 278 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2005 | 414 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2005 | 253 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 608 | 0.060 |
Why?
|
| Iron | 3 | 1994 | 1773 | 0.050 |
Why?
|
| Brain | 4 | 2019 | 26343 | 0.050 |
Why?
|
| Carbon | 1 | 2005 | 686 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1574 | 0.050 |
Why?
|
| Indium Radioisotopes | 3 | 1996 | 118 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 965 | 0.050 |
Why?
|
| Autoradiography | 2 | 2019 | 749 | 0.050 |
Why?
|
| Protons | 1 | 2005 | 1126 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2004 | 1907 | 0.040 |
Why?
|
| Liposomes | 2 | 1994 | 758 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 2 | 1985 | 1071 | 0.040 |
Why?
|
| Spiro Compounds | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10472 | 0.040 |
Why?
|
| Time Factors | 3 | 2005 | 40054 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2207 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10163 | 0.040 |
Why?
|
| Enzymes, Immobilized | 3 | 1988 | 48 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3689 | 0.040 |
Why?
|
| Mice | 5 | 2012 | 81045 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 3557 | 0.030 |
Why?
|
| Radioimmunodetection | 1 | 1995 | 46 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 1996 | 836 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5062 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2015 | 205 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4664 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 5872 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1996 | 1386 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2015 | 592 | 0.030 |
Why?
|
| Siloxanes | 1 | 1993 | 27 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 11690 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1094 | 0.030 |
Why?
|
| Asialoglycoproteins | 1 | 1993 | 19 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2255 | 0.030 |
Why?
|
| Lymphatic Metastasis | 3 | 1996 | 2906 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 738 | 0.030 |
Why?
|
| Ferrosoferric Oxide | 3 | 1994 | 360 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1996 | 520 | 0.030 |
Why?
|
| Binding Sites | 2 | 2019 | 6115 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4933 | 0.030 |
Why?
|
| Silicones | 1 | 1993 | 248 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 1993 | 222 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1372 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2015 | 621 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 1992 | 139 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1643 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7167 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 908 | 0.020 |
Why?
|
| Dogs | 2 | 2012 | 3910 | 0.020 |
Why?
|
| Troponin C | 1 | 2007 | 25 | 0.020 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1988 | 53 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2012 | 514 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1996 | 3913 | 0.020 |
Why?
|
| Streptokinase | 1 | 1988 | 188 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16665 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 148 | 0.020 |
Why?
|
| Male | 10 | 2015 | 349538 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 2479 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 727 | 0.020 |
Why?
|
| Fibrinolytic Agents | 2 | 1988 | 2156 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6382 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 893 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17400 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1385 | 0.020 |
Why?
|
| Humans | 7 | 2013 | 742088 | 0.020 |
Why?
|
| Colloids | 1 | 1984 | 136 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2012 | 1807 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 3801 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 23387 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6608 | 0.010 |
Why?
|
| Myocardium | 1 | 1995 | 4775 | 0.010 |
Why?
|
| Microspheres | 1 | 1984 | 777 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
| Liver | 2 | 1993 | 7470 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1994 | 2027 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1704 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5019 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11363 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 8925 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9274 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 18006 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14554 | 0.010 |
Why?
|
| Female | 3 | 2015 | 379592 | 0.010 |
Why?
|
| Chymotrypsin | 2 | 1986 | 149 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 47 | 0.010 |
Why?
|
| Femoral Nerve | 1 | 1994 | 39 | 0.010 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 1993 | 36 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1995 | 664 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1994 | 563 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 9325 | 0.010 |
Why?
|
| Surface Properties | 1 | 1994 | 1182 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1994 | 609 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1994 | 1183 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12071 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1915 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1993 | 1423 | 0.000 |
Why?
|
| Cyanogen Bromide | 1 | 1985 | 73 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1986 | 253 | 0.000 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1986 | 337 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 1128 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1985 | 594 | 0.000 |
Why?
|
| Fibrin | 1 | 1986 | 506 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1986 | 894 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1985 | 674 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1994 | 6191 | 0.000 |
Why?
|
| Thrombosis | 1 | 1986 | 2966 | 0.000 |
Why?
|